Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol
Abstract Background: Standard medications for opioid use disorder (MOUD) provide effective treatment pathways for recovery compared with no treatment or…